FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588490055> ?p ?o ?g. }

• W2588490055 endingPage "46" @default.
• W2588490055 startingPage "36" @default.
• W2588490055 abstract "Tubulin targeting agents have received considerable interest as a potential tumor-selective vascular disrupting agents, which represent another avenue for cancer growing therapeutic opportunities. Hence, the present study was conducted to investigate the anti-tumor activity of Combretastatin A-4 phosphate (CA4-P) and vincristine against hepatocellular carcinoma in rats, by individual administration and in combination. In vitro study was conducted using human hepatocellular carcinoma cell lines, showed that CA4-P and vincristine have a potent cell cytotoxic and tubulin inhibitory effect. In addition, a remarkable synergistic effect was observed by the simultaneous application of both drugs. Whereas in vivo study was conducted using model of rat liver cancer initiated with DENA and promoted by CCl4, showed that CA4-P and vincristine were significantly decreased liver relative weight, number of hepatic nodules and there relative volumes, tubulin content of the hepatic tissue, GSH and AFP. On the other hand, co-administration of both drugs exhibited significant further decrements in these parameters. Whereas a marked increase in MDA, carbonyl content and TNF-α inside hepatic tissue were observed in the treated groups and these increments were more prominent by co-administration of both drugs. In conclusion CA4-P showed a potential anti-cancer activity against hepatocellular carcinoma and this effect was greatly enhanced by co-administration with vincristine. Additionally, our new findings provided an important evidence that the anticancer activity of drugs with a narrow therapeutic window such as vincristine can be greatly improved by its co-administration with CA4-P providing more enhanced activity with less side effects." @default.
• W2588490055 created "2017-02-24" @default.
• W2588490055 creator A5000912075 @default.
• W2588490055 creator A5006048385 @default.
• W2588490055 creator A5052938643 @default.
• W2588490055 creator A5058492837 @default.
• W2588490055 creator A5066910034 @default.
• W2588490055 date "2017-05-01" @default.
• W2588490055 modified "2023-10-18" @default.
• W2588490055 title "Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma" @default.
• W2588490055 cites W1232010659 @default.
• W2588490055 cites W1461237605 @default.
• W2588490055 cites W1508162082 @default.
• W2588490055 cites W1606207426 @default.
• W2588490055 cites W183120241 @default.
• W2588490055 cites W1935312565 @default.
• W2588490055 cites W1965901647 @default.
• W2588490055 cites W1967411824 @default.
• W2588490055 cites W1968044936 @default.
• W2588490055 cites W1975864579 @default.
• W2588490055 cites W1976719075 @default.
• W2588490055 cites W1987703725 @default.
• W2588490055 cites W2010133479 @default.
• W2588490055 cites W2014232331 @default.
• W2588490055 cites W2016604529 @default.
• W2588490055 cites W2017180553 @default.
• W2588490055 cites W2019153783 @default.
• W2588490055 cites W2023388051 @default.
• W2588490055 cites W2027756656 @default.
• W2588490055 cites W2030488247 @default.
• W2588490055 cites W2030992915 @default.
• W2588490055 cites W2032583704 @default.
• W2588490055 cites W2037294201 @default.
• W2588490055 cites W2040740629 @default.
• W2588490055 cites W2041060558 @default.
• W2588490055 cites W2055402012 @default.
• W2588490055 cites W2066916074 @default.
• W2588490055 cites W2069331778 @default.
• W2588490055 cites W2070200983 @default.
• W2588490055 cites W2074191044 @default.
• W2588490055 cites W2081626155 @default.
• W2588490055 cites W2096439168 @default.
• W2588490055 cites W2102402698 @default.
• W2588490055 cites W2109414919 @default.
• W2588490055 cites W2110317479 @default.
• W2588490055 cites W2115112566 @default.
• W2588490055 cites W2124472420 @default.
• W2588490055 cites W2140097914 @default.
• W2588490055 cites W2152013058 @default.
• W2588490055 cites W2157479632 @default.
• W2588490055 cites W2166278118 @default.
• W2588490055 cites W2176090910 @default.
• W2588490055 cites W2232266376 @default.
• W2588490055 cites W2263023695 @default.
• W2588490055 cites W231341965 @default.
• W2588490055 cites W2321728135 @default.
• W2588490055 cites W2352888873 @default.
• W2588490055 cites W2379622343 @default.
• W2588490055 cites W2409227936 @default.
• W2588490055 cites W2526121940 @default.
• W2588490055 cites W383619729 @default.
• W2588490055 cites W5517662 @default.
• W2588490055 cites W57121555 @default.
• W2588490055 cites W749205244 @default.
• W2588490055 doi "https://doi.org/10.1016/j.biopha.2017.02.019" @default.
• W2588490055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28214686" @default.
• W2588490055 hasPublicationYear "2017" @default.
• W2588490055 type Work @default.
• W2588490055 sameAs 2588490055 @default.
• W2588490055 citedByCount "16" @default.
• W2588490055 countsByYear W25884900552018 @default.
• W2588490055 countsByYear W25884900552019 @default.
• W2588490055 countsByYear W25884900552020 @default.
• W2588490055 countsByYear W25884900552021 @default.
• W2588490055 countsByYear W25884900552023 @default.
• W2588490055 crossrefType "journal-article" @default.
• W2588490055 hasAuthorship W2588490055A5000912075 @default.
• W2588490055 hasAuthorship W2588490055A5006048385 @default.
• W2588490055 hasAuthorship W2588490055A5052938643 @default.
• W2588490055 hasAuthorship W2588490055A5058492837 @default.
• W2588490055 hasAuthorship W2588490055A5066910034 @default.
• W2588490055 hasConcept C126322002 @default.
• W2588490055 hasConcept C150903083 @default.
• W2588490055 hasConcept C185592680 @default.
• W2588490055 hasConcept C20418707 @default.
• W2588490055 hasConcept C207001950 @default.
• W2588490055 hasConcept C2776231280 @default.
• W2588490055 hasConcept C2776694085 @default.
• W2588490055 hasConcept C2776755627 @default.
• W2588490055 hasConcept C2778019345 @default.
• W2588490055 hasConcept C2778275628 @default.
• W2588490055 hasConcept C2779429289 @default.
• W2588490055 hasConcept C502942594 @default.
• W2588490055 hasConcept C71924100 @default.
• W2588490055 hasConcept C84425145 @default.
• W2588490055 hasConcept C86803240 @default.
• W2588490055 hasConcept C95444343 @default.
• W2588490055 hasConcept C98274493 @default.

• next